[177Lu]Lu-BQ7876

· Tomsk National Research Medical Center of the Russian Academy of Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for [177Lu]Lu-BQ7876, covering 2025-04-09 to 2025-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Evaluation of [177Lu]Lu-BQ7876 for Targeting of Prostate-Specific Membrane Antigen [Phase 1]